Kenvue Inc. (NYSE:KVUE) ("Kenvue"), the world's largest pure-play consumer health company by revenue, today announced that its financial results for the second quarter ending July 2, 2023, will be released before market open on July 20, 2023.

The company will host a conference call and webcast at 7:30 a.m. Eastern Time to report its second quarter results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or 201-689-8779 from international locations. A live webcast of the conference call will be available at https://investors.kenvue.com. A replay will be available approximately two hours after the live event.

About Kenvue

Kenvue is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage and propelled forward by science, our iconic brands—including AVEENO^®, BAND-AID^® Brand Adhesive Bandages, JOHNSON'S^®, LISTERINE^®, NEUTROGENA^®, TYLENOL^® and ZYRTEC^® — are recommended by health care professionals and can be trusted by consumers who use our products to improve their daily lives. Our team members share a digital-first mindset, with an approach to innovation grounded in deep human insights and work every day to earn a place for our products in consumers' hearts and homes. At Kenvue, we believe everyday care can not only make people well; it can make them whole. Learn more at www.kenvue.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230606005925/en/

Kenvue to Announce Second Quarter 2023 Results on July 20, 2023